RNA scientist | Assoc. Prof. @uni_copenhagen and @lundbeckfonden Fellow | Editor @Moltherapy Nucleic Acids

Arhus, Denmark
Joined November 2010
Xavier Bofill De Ros retweeted
The ERC just adjusted its resubmission rules after backlash. But this episode reveals something deeper. There are two strategic mistakes in how Europe is handling frontier research. 🧵👇🏼
NEWS: The ERC Scientific Council has listened to the concerns from members of the research community about changes to the re-submission rules, intended to manage the surge in demand for grants. The Scientific Council will readjust some of the changes: link.europa.eu/TBqRQJ
2
9
1
49
14,936
Peer review was supposed to be science’s quality filter, but somewhere along the way it started acting more like a bouncer who only lets in the regulars. It’s slow, it tends to favor established labs and familiar names, and it gets uncomfortable around anything too unconventional. Papers loaded with mountains of data tend to cruise through, while bold ideas that actually challenge the consensus get stuck in limbo or turned away at the door. The irony is that where a paper gets published almost never determines its real worth. What actually matters is what the scientific community does with it afterward, whether people cite it, argue with it, build on it, or use it to blow up a long-held assumption. That’s where the value lives, not in the journal’s logo. A major survey a few years back found that roughly 70% of researchers think the current system is fundamentally broken, and it’s not hard to see why. Publicly funded research hides behind paywalls, editors chase whatever topic is hot that month, and the whole incentive structure pushes toward safe bets over genuinely risky and potentially important work. Science has always been complicated and deeply human and full of ego and inertia, but the conversation is shifting.
Readers added context they thought people might want to know
La portada es falsa. Las fechas de la portada de la imagen corresponden a la edición doble de vacaciones. economist.com/weeklyedition/…
106
689
103
1,879
135,288
I’m excited to share that soon, I’ll be joining the Department of Drug Design and Pharmacology @uni_copenhagen. I’m very much looking forward to contributing my work on small RNAs and the shared ambitions in nucleic acid–based therapeutics. pkunet-shared.ku.dk/newsroom…
1
2
77
At the same time, I want to express my deep gratitude to @MolBiolAU and for being instrumental in helping me establish my independent research group. I’m incredibly grateful for the support, trust, and friendships that marked my time in Aarhus. 💙🧬
43
Xavier Bofill De Ros retweeted
📢 Buscamos candidatos/as para beca postdoctoral @FundacionAreces Proyecto: tumores pediátricos en modelos murinos, metabolismo del RNA y dianas terapéuticas. 📍 Copenhagen, Denmark 🇩🇰 ⏳ Deadline: feb 2026 📩 Escríbeme por DM
1
122
📢 Buscamos candidatos/as para beca postdoctoral @FundacionAreces Proyecto: tumores pediátricos en modelos murinos, metabolismo del RNA y dianas terapéuticas. 📍 Copenhagen, Denmark 🇩🇰 ⏳ Deadline: feb 2026 📩 Escríbeme por DM
1
122
Getting started with the first session of the Aarhus Cancer Genomics Symposium! Ready for an inspiring day! – at Arhus, Denmark
4
397
Getting started for some exciting day of Argonautes‼️Thanks @Argonautes_conf for this excellent program #ArgonautesConference – at Copenhagen, Denmark
7
556
Xavier Bofill De Ros retweeted
We report that circular RNA circHIPK3 sequesters IGF2BP2 to regulate cancer targets. Surprisingly, this is possible even though circHIPK3 is outnumbered by orders of magnitude by its client protein. Great collab with @TrineLineOkholm and @skouped doi.org/10.7554/eLife.91783.… 👇
1
1
5
264
Opening the annual meeting of our department!! An exciting day to learn about the science done by our colleagues at @MolBiolAU 🧪🧫🧬 – at Arhus, Denmark
3
441
Xavier Bofill De Ros retweeted
2
5
304
Xavier Bofill De Ros retweeted
AlphaFold2 and RoseTTAFold are limited to predicting the 3D structure of proteins. A new all-atom method models complete biomolecular assemblies, including proteins, nucleic acids, small molecules, metals, and covalent modifications. #NBThighlight science.org/doi/10.1126/scie…
1
221
6
692
91,936
Thank you so much @PetzoldKatja for your inspiring Kjeldgaard lecture about microRNA-target structure and dynamics. We really enjoyed having you at @MolBiolAU – at Arhus, Denmark
1
6
461
Xavier Bofill De Ros retweeted
How does cellular stress affect #RNA? We sequence entire RNA molecules with @nanopore sequencing. We find 👉Global RNA decay mediated by XRN1, independent of poly(A) tail! 👉Decay absolutely depends on stress-granule formation! biorxiv.org/content/10.1101/…
2
35
2
168
16,313
Xavier Bofill De Ros retweeted
Extended call! We are still looking for a talented postdoc to join our team. If you are excited about pancreatic cancer, metabolism and immune modulation , this is for you 👇🏻 international.au.dk/about/pr…
14
15
2,520
Xavier Bofill De Ros retweeted
UPDATED: our massive database of funding opportunities for EARLY-CAREER RESEARCHERS For each of the 496 (!!) listed opportunity, we provide description, link to funder, $ amount, deadline, and eligibility criteria (e.g. citizenship) Dowload here: research.jhu.edu/rdt/funding…
2
240
3
627
120,178
Xavier Bofill De Ros retweeted
We are looking for a postdoc to join our growing lab in Denmark! If you are interested in pancreatic cancer metabolism and interactions with the TME, check this out 👇🏻. Deadline: 17 Dec. Please spread the word. health.au.dk/en/about-health…
1
23
5
35
6,944
We are thankful for the support of #riisfort foundation. It will help us investigate the molecular mechanisms that link the loss of activity of the RNA exonuclease DIS3L2 and kidney cancer that affects children.
1
1
1
12
1,031
Xavier Bofill De Ros retweeted
Say hello to RNAcanvas and XRNA-React! 🌟 Now you can visualise RNA secondary structures in #R2DT and edit them to create publication quality diagrams, all in your browser 🎨✨ docs.r2dt.bio/en/latest/edit…
3
42
2
132
13,563